Safety of fexofenadine in children treated for seasonal allergic rhinitis
- 31 July 2001
- journal article
- clinical trial
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 87 (1) , 22-26
- https://doi.org/10.1016/s1081-1206(10)62317-4
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The systemic safety of fexofenadine HClClinical and Experimental Allergy, 1999
- Cardiovascular Safety of FexofenadineHClThe American Journal of Cardiology, 1999
- Safety and Efficacy of Once-Daily Fexofenadine HCl in the Treatment of Autumn Seasonal Allergic RhinitisAllergy and Asthma Proceedings, 1999
- Effectiveness and Safety of Fexofenadine, a New Nonsedating H1-Receptor Antagonist, in the Treatment of Fall AllergiesAllergy and Asthma Proceedings, 1998
- Fexofenadine hydrochloride in the treatment of chronic idiopathic urticaria: A placebo-controlled, parallel-group, dose-ranging studyJournal of Dermatological Treatment, 1998
- Efficacy and Safety of Fexofenadine Hydrochloride for Treatment of Seasonal Allergic RhinitisAnnals of Allergy, Asthma & Immunology, 1997
- Prevalence of allergic rhinitis in the United StatesJournal of Allergy and Clinical Immunology, 1997
- Sedative effects of antihistamines: safety, performance, learning, and quality of lifeClinical Therapeutics, 1997
- Learning Impairment and Allergic RhinitisAllergy and Asthma Proceedings, 1996
- An overview of current pharmacotherapy in perennial rhinitisJournal of Allergy and Clinical Immunology, 1995